AzTrials
AzTrials

Post-Tonsillectomy BleedingNCT07763704

The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy Bleeding

An observational study of Post-Tonsillectomy Bleeding, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

Post-tonsillectomy hemorrhage (PTH) is one of the most common and potentially life-threatening complications of tonsillectomy. Secondary PTH (Bleeding occurring >24 hours post-operatively) is of particular clinical significance. Tonsillectomy is a frequently performed procedure at Assiut University Hospital (AUH). Read more about this study

Who is it for?
Any age
Conditions the study is for
Post-Tonsillectomy Bleeding
How many people
100 participants
Where
No sites listed yet
Study dates
Sep 2026to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Secondary PTH (bleeding >24 hours post-tonsillectomy)

Who may be able to join

  • Secondary PTH (bleeding >24 hours post-tonsillectomy)
  • Tonsillectomy surgical technique: cold steel, bipolar diathermy, or Coblation
  • Any patient age (pediatric and adult patient are included)
  • Presenting to the AUH Emergency Department or ENT clinic
  • Informed consent obtained (written parental consent + written child assent for patients under 18 years)

Who cannot join

  • Primary PTH (bleeding ≤24 hours post-op)
  • Tonsillectomy technique other than the three study techniques (e.g., laser, harmonic scalpel)
  • External approach tonsillectomy
  • Known bleeding disorder (pre-existing coagulopathy)
  • Concurrent head and neck malignancy
  • Refusal of informed consent

About this study

Post-tonsillectomy hemorrhage (PTH) is one of the most common and potentially life-threatening complications of tonsillectomy.

  • Secondary PTH (Bleeding occurring >24 hours post-operatively) is of particular clinical significance.
  • Tonsillectomy is a frequently performed procedure at Assiut University Hospital (AUH).
  • However, no local prospective data exists comparing secondary PTH rates across techniques, or systematically characterizing its causes.
  • This study addresses this gap by comparing rates, and analysis of causes.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07763704
Study groupRoleWhat they receive
study groupSecondary PTH (bleeding >24 hours post-tonsillectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. secondary post-tonsillectomy hemorrhage

    bleeding from the throat that happens more than 24 hours after surgery, most commonly between 5 and 10 days post-op

    Measured: 10 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionSep 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07763704
Sponsor's protocol ID
2ry tonsillectomy bleeding
Status last verified
Aug 2026
First submitted
10 Aug 2026
Last updated
13 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post-Tonsillectomy Bleeding, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

secondary post-tonsillectomy hemorrhage (time frame: 10 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in